Wednesday, September 30, 2020
Home > Biopharma

PRNB Stock Up 1% as Sanofi Mulls Buying Principia Biopharma for $50B

Sanofi is looking at potential acquisitions of U.S. biotechnology companies including Principia Biopharma, as it looks for innovative treatments for clinical areas including multiple sclerosis and immune disorders. PRNB stock price is up.Sanofi (EPA: SAN) is mulling potential buying of U.S. biotechnology companies including Principia Biopharma Inc (NASDAQ: PRNB) as

Read More